Articles:

PH Fischer and D Baxter

Enzyme regulatory site-directed drugs. MOdulation of thymidine triphosphate inhibition of thymidine kinase by 5'-amino-5'- deoxythymidine
Mol Pharmacol 1982 22: 231-234. [Abstract] [PDF]  

JD Duncan and AK Cho

N-oxidation of phentermine to N-hydroxyphentermine by a reconstituted cytochrome P-450 oxidase system from rabbit liver
Mol Pharmacol 1982 22: 235-238. [Abstract] [PDF]  

WG Jr Harrelson and RP Mason

Microsomal reduction of gentian violet. Evidence for cytochrome P-450- catalyzed free radical formation
Mol Pharmacol 1982 22: 239-242. [Abstract] [PDF]  

B Ilien, H Gorissen, and PM Laduron

Characterization of solubilized serotonin (S2) receptors in rat brain
Mol Pharmacol 1982 22: 243-249. [Abstract] [PDF]  

KM Murphy and SH Snyder

Heterogeneity of adenosine A1 receptor binding in brain tissue
Mol Pharmacol 1982 22: 250-257. [Abstract] [PDF]  

RJ Hughes, MR Boyle, RD Brown, P Taylor, and PA Insel

Characterization of coexisting alpha 1- and beta 2-adrenergic receptors on a cloned muscle cell line, BC3H-1
Mol Pharmacol 1982 22: 258-266. [Abstract] [PDF]  

SY Cech and ME Maguire

Magnesium regulation of the beta-receptor-adenylate cyclase complex. I. Effects of manganese on receptor binding and cyclase activation
Mol Pharmacol 1982 22: 267-273. [Abstract] [PDF]  

ME Maguire

Magnesium regulation of the beta-receptor-adenylate cyclase complex. II. Sc3+ as a Mg2 antagonist
Mol Pharmacol 1982 22: 274-280. [Abstract] [PDF]  

MP Seiler and R Markstein

Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding
Mol Pharmacol 1982 22: 281-289. [Abstract] [PDF]  

A De Lean, BF Kilpatrick, and MG Caron

Dopamine receptor of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists
Mol Pharmacol 1982 22: 290-297. [Abstract] [PDF]  

BF Kilpatrick, A De Lean, and MG Caron

Dopamine receptor of the porcine anterior pituitary gland. Effects of N- ethylmaleimide and heat on ligand binding mimic the effects of guanine nucleotides
Mol Pharmacol 1982 22: 298-303. [Abstract] [PDF]  

JS Aguilar, PJ Salas, and E De Robertis

Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate
Mol Pharmacol 1982 22: 304-309. [Abstract] [PDF]  

RB Meeker and TK Harden

Muscarinic cholinergic receptor-mediated activation of phosphodiesterase
Mol Pharmacol 1982 22: 310-319. [Abstract] [PDF]  

R Grandt, K Aktories, and KH Jakobs

Guanine nucleotides and monovalent cations increase agonist affinity of prostaglandin E2 receptors in hamster adipocytes
Mol Pharmacol 1982 22: 320-326. [Abstract] [PDF]  

RF Squires and E Saederup

gamma-aminobutyric acid receptors modulate cation binding sites coupled to independent benzodiazepine, picrotoxin, and anion binding sites
Mol Pharmacol 1982 22: 327-334. [Abstract] [PDF]  

RL Kochman and JD Hirsch

Thermodynamic changes associated with benzodiazepine and alkyl beta- carboline-3-carboxylate binding to rat brain homogenates
Mol Pharmacol 1982 22: 335-341. [Abstract] [PDF]  

P Chatelain, P Robberecht, M Waelbroeck, P De Neef, J Camus, and J Christophe

Thermodependence of guanine nucleotide-activated rat cardiac adenylate cyclase activity. Effect of cholera toxin pretreatment
Mol Pharmacol 1982 22: 342-348. [Abstract] [PDF]  

BV Cheney, RA Lahti, C Barsuhn, and DD Gay

An analysis of binding at the opioid receptor based upon an agonist/antagonist two-state model
Mol Pharmacol 1982 22: 349-359. [Abstract] [PDF]  

R Jr McGee and JG Kenimer

The effects of exposure to unsaturated fatty acids on opiate receptors, prostaglandin E1 receptors, and adenylate cyclase activity of neuroblastoma x glioma hybrid cells
Mol Pharmacol 1982 22: 360-368. [Abstract] [PDF]  

P Pennefather and DM Quastel

Modification of dose-response curves by effector blockade and uncompetitive antagonism
Mol Pharmacol 1982 22: 369-380. [Abstract] [PDF]  

K Hanif, HJ Goren, MD Hollenberg, and K Lederis

Oxytocin action. Mechanisms for insulin-like activity in isolated rat adipocytes
Mol Pharmacol 1982 22: 381-388. [Abstract] [PDF]  

R Nehmad, H Nadler, and R Simantov

Effects of acute and chronic morphine treatment of calmodulin activity of rat brain
Mol Pharmacol 1982 22: 389-394. [Abstract] [PDF]  

JA Norman and M Staehelin

Calmodulin inhibitors activate glycogen phosphorylase B to A conversion in C6 glioma cells
Mol Pharmacol 1982 22: 395-402. [Abstract] [PDF]  

T Tanaka, T Ohmura, and H Hidaka

Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives
Mol Pharmacol 1982 22: 403-407. [Abstract] [PDF]  

T Tanaka, T Ohmura, T Yamakado, and H Hidaka

Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives
Mol Pharmacol 1982 22: 408-412. [Abstract] [PDF]  

K Gietzen, A Wuthrich, and H Bader

Effects of microtubular inhibitors on plasma membrane calmodulin- dependent Ca2+-transport ATPase
Mol Pharmacol 1982 22: 413-420. [Abstract] [PDF]  

AW Tank and N Weiner

Induction of tyrosine hydroxylase by glucocorticoids in mouse neuroblastoma cells. Enhancement of the induction by cyclic AMP
Mol Pharmacol 1982 22: 421-430. [Abstract] [PDF]  

WE Klunk, DF Covey, and JA Ferrendelli

Comparison of epileptogenic properties of unsubstituted and beta-alkyl- substituted gamma-butyrolactones
Mol Pharmacol 1982 22: 431-437. [Abstract] [PDF]  

WE Klunk, DF Covey, and JA Ferrendelli

Anticonvulsant properties of alpha, gamma, and alpha, gamma-substituted gamma-butyrolactones
Mol Pharmacol 1982 22: 438-443. [Abstract] [PDF]  

WE Klunk, DF Covey, and JA Ferrendelli

Structure-activity relationships of alkyl-substituted gamma- butyrolactones and succinimides
Mol Pharmacol 1982 22: 444-450. [Abstract] [PDF]  

GM Keller, CR Turner, and CR Jefcoate

Kinetic determinants of benzo[a]pyrene metabolism to dihydrodiol epoxides by 3-methylcholanthrene-induced rat liver microsomes
Mol Pharmacol 1982 22: 451-458. [Abstract] [PDF]  

SM Adams and LS Kaminsky

Molecular orbital studies of epoxide stability of carcinogenic polycyclic aromatic hydrocarbon diol epoxides
Mol Pharmacol 1982 22: 459-464. [Abstract] [PDF]  

AK Cho, MS Maynard, RM Matsumoto, B Lindeke, U Paulsen, and GT Miwa

The opposing effects of N-hydroxyamphetamine and N-hydroxyphentermine on the H2O2 generated by hepatic cytochrome P-450
Mol Pharmacol 1982 22: 465-470. [Abstract] [PDF]  

ED Kharasch and RF Novak

Inhibition of microsomal oxidative drug metabolism by 1,4-bis (2-[(2- hydroxyethyl)amino]-ethylamino)-9,10-anthracenedione diacetate, a new antineoplastic agent
Mol Pharmacol 1982 22: 471-478. [Abstract] [PDF]  

B Andersson, M Nordenskjold, A Rahimtula, and P Moldeus

Prostaglandin synthetase-catalyzed activation of phenacetin metabolites to genotoxic products
Mol Pharmacol 1982 22: 479-485. [Abstract] [PDF]  

BC Baguley and BF Cain

Comparison of the in vivo and in vitro antileukemic activity of monosubstituted derivatives of 4'-(9-acridinylamino)methanesulfon-m- anisidide
Mol Pharmacol 1982 22: 486-492. [Abstract] [PDF]  

DA Gewirtz, JK Randolph, and ID Goldman

Catecholamine-induced release of the folic acid analogue, methotrexate, from rat hepatocytes in suspension. An alpha-adrenergic phenomenon
Mol Pharmacol 1982 22: 493-499. [Abstract] [PDF]  

RM Denney, NT Patel, RR Fritz, and CW Abell

A monoclonal antibody elicited to human platelet monoamine oxidase. Isolation and specificity for human monoamine oxidase B but not A
Mol Pharmacol 1982 22: 500-508. [Abstract] [PDF]  

JG Conway, FC Kauffman, S Ji, and RG Thurman

Rates of sulfation and glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule
Mol Pharmacol 1982 22: 509-516. [Abstract] [PDF]  

KM Rose, TB Leonard, and TH Carter

Effects of adenine nucleosides on RNA synthesis in adenovirus-infected cells. 9-beta-D-Arabinofuranosyladenine as a selective inhibitor of RNA polyadenylation
Mol Pharmacol 1982 22: 517-523. [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.